Healthy adults
Conditions
Interventions
Consumption of test food
Consumption of control food
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 18 to 30 (2) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of diabetes mellitus, liver disease, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious diseases. (2) Subjects who have undergone gastrointestinal surgery (3) Subjects showing abnormal liver and kidney function test values. (4) Subjects who are allergic to food and drugs (5) Subjects with anemia symptoms (6) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (7) Subjects with extremely irregular eating habits (8) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the study period (9) Subjects who are continuously treated with medications (including OTC, prescription drugs) (10) Subjects who drink more than 40g of ayarage daily pure alcohol (11) Subjects who smoke an average of 21 or more cigarettes a day (12) Subjects who are currently participating in other clinical studies or are scheduled to participate in research at the start of this study. (13) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total urine volume at the end of the observation period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight Body temperature Amount of sweating Serum osmolality | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed